CAMBRIDGE, Mass.--(BUSINESS WIRE)--Xanthus Pharmaceuticals, Inc., a privately-held oncology drug development company, today announced that Richard T. Dean, Ph.D., President and CEO of Xanthus, will present a company overview and update on the Company’s oncology pipeline at the BIO CEO & Investor Conference on Wednesday, February 14th at 12:45 p.m. at the Waldorf=Astoria Hotel in New York. Dr. Robert L. Capizzi, M.D., F.A.C.P., Senior Vice President and Chief Medical Officer will participate in the Blood-Borne Cancers - The Alphabet Soup of Leukemias panel scheduled on Monday, February 12th at 3:30 p.m., also at the Waldorf=Astoria Hotel. A live audio webcast of the presentation will be available on the Company’s website located at http://www.xanthus.com. A replay of the presentation will be posted on the Xanthus website approximately thirty minutes after the event.
